Showing results (51-60 of 82) with videos related to
Sort By:
Pageof 9
Histochemistry and Cell Biology|October 22, 2009
Melanoma progression exhibits a significant impact on connexin expression patterns in the epidermal tumor microenvironmentNikolas K Haass, D Ripperger, E Wladykowski, et al.Journal of the Royal Society, Interface|April 6, 2022
A stochastic mathematical model of 4D tumour spheroids with real-time fluorescent cell cycle labellingJonah J Klowss, Alexander P Browning, Ryan J Murphy, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2011
Modulation of NOXA and MCL-1 as a strategy for sensitizing melanoma cells to the BH3-mimetic ABT-737Keryn M Lucas, Nethia Mohana-Kumaran, Diana Lau, et al.JAMA Dermatology|June 27, 2014
Detection of primary melanoma in individuals at extreme high risk: a prospective 5-year follow-up studyFergal J Moloney, Pascale Guitera, Elliot Coates, et al.Pigment Cell & Melanoma Research|October 27, 2010
PLX4032, a potent inhibitor of the B-Raf V600E oncogene, selectively inhibits V600E-positive melanomasJohn T Lee, Ling Li, Patricia A Brafford, et al.The Journal of Investigative Dermatology|December 27, 2021
Reciprocal Regulation of BRN2 and NOTCH1/2 Signaling Synergistically Drives Melanoma Cell Migration and InvasionMitchell E Fane, Yash Chhabra, Loredana Spoerri, et al.Cancer Research|January 11, 2007
An organometallic protein kinase inhibitor pharmacologically activates p53 and induces apoptosis in human melanoma cellsKeiran S M Smalley, Rooha Contractor, Nikolas K Haass, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 15, 2018
Endogenous Replication Stress Marks Melanomas Sensitive to CHEK1 Inhibitors In VivoZay Yar Oo, Alexander J Stevenson, Martina Proctor, et al.Cancers|August 7, 2021
Targeting Replication Stress Using CHK1 Inhibitor Promotes Innate and NKT Cell Immune Responses and Tumour RegressionMartina Proctor, Jazmina L Gonzalez Cruz, Sheena M Daignault-Mill, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2017
Acetylsalicylic Acid Governs the Effect of Sorafenib in RAS-Mutant CancersHeinz Hammerlindl, Dinoop Ravindran Menon, Sabrina Hammerlindl, et al.Pageof 9